No correlation was observed between HER-2 status and age, gender, tumor location, infiltration level, stage, grade, lymph node status, venous, lymphatic invasion, and overall survival of the ESCC patients. This evidence concerns the gene ERBB2 and esophageal squamous cell carcinoma.